TagPharmaceutical Benefits Scheme (PBS)

Updated guidelines for PEP (Post-Exposure Prophylaxis) after non-occupational and occupational exposure to HIV 

By J Pope
In HIV
2 Min Read
U

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), June 2023 ASHM has updated the National Guidelines for Post-Exposure Prophylaxis (PEP) after non-occupational and occupational exposure to HIV .  These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure...

Read onRead later

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence

By J Pope
In Hepatitis, HIV
2 Min Read
T

van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus...

Read onRead later

Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting

By J Pope
In HIV
2 Min Read
U

Chidwick Kendal, Pollack Allan, Busingye Doreen, Norman Sarah, Grulich Andrew, Bavinton Benjamin, Guy Rebecca, Medland Nick (2022) Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: a longitudinal observational study. Sexual Health 19, 101-111. Abstract: Background: Pre-exposure prophylaxis (PrEP) became available through the Australian...

Read onRead later

What makes gay and bisexual men in Australia choose not to take PrEP?

By J Pope
In Gay Lesbian & Bisexual Health, HIV, Safer sex
1 Min Read
W

nam/aidsmap, 14 April 2022 Perceived irrelevance, lack of awareness, problems with access, side effects, negative social impacts, and concerns about lack of STI protection, effectiveness and adherence are the most common reasons for not using PrEP among gay and bisexual men in Australia. This is according to a study recently published in the journal Behavioral Medicine which analysed reasons for...

Read onRead later

Continuing declines in HIV diagnoses thanks to successful PrEP rollout in NSW

By J Pope
In Gay Lesbian & Bisexual Health, HIV
1 Min Read
C

 Kirby Institute at UNSW, Friday July 2nd, 2021 New research from the Kirby Institute at UNSW Sydney shows that HIV transmissions are at historically low rates among almost 10,000 high-risk gay and bisexual men on pre-exposure prophylaxis (PrEP), the HIV prevention medication. Low HIV rates persisted after PrEP moved from being available cost-free as part of a NSW clinical trial, to being...

Read onRead later

Agenda 2025: Ending HIV transmission in Australia in four years

By J Pope
In HIV
2 Min Read
A

Australian Federation of AIDS Organisations (AFAO), 17th June 2021 Agenda 2025 is a fully costed plan which draws upon evidence based research and is backed by top researchers, leaders, and clinicians in Australia’s community-led HIV response.  Australia can end HIV transmission within four short years, averting over 6,000 infections by 2030 and saving $1.4 billion in health costs, according to a...

Read onRead later

Your sidebar area is currently empty. Hurry up and add some widgets.